Table 2 Baseline characteristics of participants depending on the type intervention assigned*
Standard intervention (n = 154) | Intensive intervention (n = 146) | |
|---|---|---|
Women, n (%) | 98(63.6) | 92(63.0) |
Men, n(%) | 56(36.4) | 54(37.0) |
Age in years | 58.6 ± 10.6 | 56.8 ± 10.6 |
Fibrinogen, mg/dl | 368.7 ± 64.5 | 364.9 ± 59.4 |
Total cholesterol, mg/dl | 210.2 ± 25.5 | 211.1 ± 26.7 |
Tryglicerides, mg/dl | 116.6 ± 59.6 | 116.5 ± 54.3 |
cHDL, mg/dl | 55.2 ± 13.1 | 54.2 ± 12.0 |
cLDL, mg/dl | 134.3 ± 28.6 | 134.6 ± 26.9 |
Basal glucose, mg/dl | 108.3 ± 33.1 | 108.5 ± 35.9 |
Hematocrit,% | 42.0 ± 3.7 | 42.1 ± 3.4 |
Leucocytes, 10e12/l | 7.6 ± 3.0 | 7.4 ± 2.0 |
Platelets, 10e9/l | 243.0 ± 60.2 | 252.3 ± 67.6 |
Weight, kg | 76.7 ± 12.9 | 75.7 ± 13.1 |
Height, cm | 158.7 ± 8.4 | 158.7 ± 9.8 |
SBP, mmHg | 134.7 ± 18.0 | 133.8 ± 17.4 |
DBP, mmHg | 81.7 ± 9.4 | 80.7 ± 9.8 |
BMI, kg/m2 | 30.5 ± 5.1 | 30.3 ± 5.8 |
Obesity, (%) | (55.5%) | (46.8%) |
Tobacco, (%) | (26.8%) | (31.9%) |
Hipertensión arterial(%) | (41.4%) | (42.7%) |
Diabetes mellitus(%) | (15.1%) | (11.9%) |
HbA1c% in diabetic patients | 6.9 ± (1.7) | 7.1 ± (1.5) |